Notal Vision
Tzviah Nissan is a seasoned accounting professional with extensive experience in financial bookkeeping and management. Currently serving as a Senior Bookkeeper at Notal Vision since August 2023, Tzviah previously held the position of Senior Accounting Bookkeeper at Personetics, where end-to-end financial bookkeeping was a key responsibility from March 2022 to August 2023. Tzviah's career also includes significant roles such as Accounting Bookkeeper at LESICO Group LTD from February 2018 to February 2022, Company Accountant at קלסיקלטת clasikaletet from August 2015 to February 2018, and Financial Controller at IBM from September 1994 to May 2015, focusing on financial planning and project control in communication networks. Tzviah holds a degree in Accounting and Finance from The College of Management Academic Studies.
This person is not in any offices
Notal Vision
Notal Vision is a patient-centric ophthalmic remote monitoring services provider extending retinal disease monitoring from the clinic to the home, providing physicians with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help preserve patients’ vision. The Notal Vision Monitoring Center is a remote, Medicare credentialed ophthalmic provider and the epicenter of patient engagement. Led by practicing ophthalmologists and supported by certified ophthalmic professionals, the Monitoring Center offers a comprehensive nationwide age-related macular degeneration (AMD) home monitoring service for referred patients. The ForeseeHome® AMD Monitoring Program helps physicians detect the conversion to wet AMD early, leading to earlier treatment intervention and better visual outcomes. Our Home OCT pipeline technology will provide patient-initiated retinal OCT scans to support the management of patients with neovascular retinal diseases, complementing existing in-office imaging and standard of care treatments as well as emerging longer acting drugs and drug delivery systems.